Masimo/$MASI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Masimo
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
Ticker
$MASI
Sector
Primary listing
Employees
2,200
Headquarters
Website
Masimo Metrics
BasicAdvanced
$9.3bn
-
-$2.80
1.20
-
Price and volume
Market cap
$9.3bn
Beta
1.2
52-week high
$179.00
52-week low
$125.94
Average daily volume
853k
Financial strength
Current ratio
2.492
Quick ratio
1.291
Long term debt to equity
75.555
Total debt to equity
77.551
Interest coverage (TTM)
9.23%
Profitability
EBITDA (TTM)
345.3
Gross margin (TTM)
61.80%
Net profit margin (TTM)
-9.92%
Operating margin (TTM)
20.07%
Effective tax rate (TTM)
23.81%
Revenue per employee (TTM)
$690,000
Management effectiveness
Return on assets (TTM)
8.86%
Return on equity (TTM)
23.43%
Valuation
Price to revenue (TTM)
6.269
Price to book
12.9
Price to tangible book (TTM)
16.38
Price to free cash flow (TTM)
49.57
Free cash flow yield (TTM)
2.02%
Free cash flow per share (TTM)
3.603
Growth
Revenue change (TTM)
9.44%
Earnings per share change (TTM)
-50.07%
3-year revenue growth (CAGR)
-9.14%
10-year revenue growth (CAGR)
9.37%
3-year earnings per share growth (CAGR)
2.47%
10-year earnings per share growth (CAGR)
6.08%
What the Analysts think about Masimo
Analyst ratings (Buy, Hold, Sell) for Masimo stock.
Masimo Financial Performance
Revenues and expenses
Masimo Earnings Performance
Company profitability
Masimo News
AllArticlesVideos
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
Business Wire·4 weeks ago
Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI
Business Wire·3 months ago
What's Happening With Masimo Stock?
Forbes·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Masimo stock?
Masimo (MASI) has a market cap of $9.3B as of May 07, 2026.
What is the P/E ratio for Masimo stock?
The price to earnings (P/E) ratio for Masimo (MASI) stock is 0 as of May 07, 2026.
Does Masimo stock pay dividends?
No, Masimo (MASI) stock does not pay dividends to its shareholders as of May 07, 2026.
When is the next Masimo dividend payment date?
Masimo (MASI) stock does not pay dividends to its shareholders.
What is the beta indicator for Masimo?
Masimo (MASI) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.